Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 EBA, safety and pharmacokinetics study of oral LCB01-0371 in adults with smear-positive pulmonary tuberculosis
KCT0003975Phase 2Recruiting
- Sponsor
- LigaChem Biosciences
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of delpazolid in pulmonary tuberculosis (TB), sponsored by LigaChem Biosciences. Started Dec 2016; status: recruiting.
02
Drugs
delpazolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on KCT0003975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003975.